Literature DB >> 17442703

Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain.

Angela Dominguez1, Pere Plans, Jordi Espuñes, Josep Costa, Nuria Torner, Neus Cardeñosa, Antoni Plasencia, Lluís Salleras.   

Abstract

BACKGROUND: The objective of the study was to determine the prevalence of rubella antibodies in representative samples of pregnant women in Catalonia.
METHODS: A representative sample of pregnant women in Catalonia was obtained by random sampling by clusters (hospitals with maternity units) stratified by provinces. Blood was obtained from the umbilical cord at childbirth in 1538 women (of whom 308 were immigrants) and was tested for rubella antibodies by ELISA (Enzime-linked immunosorbent assay).
RESULTS: The global prevalence of antibodies was 93.4% [95% confidence interval (CI): 93.3-93.5] and was significantly higher in indigenous women (94.9;95%CI:93.3-95.9) compared with immigrants [89.0; 95%CI: 85.5-92.5 (P<0. 0001)] with crude Odds ratio (OR) of 2.15 (95%CI: 1.40-3.32).The prevalence was higher in women living in rural habitats (97%) and those in higher social classes (96.3%); OR 2.54 (95%CI: 1.22-5.30) and 2.17 (95%CI: 1.24-3.81), respectively.
CONCLUSION: Fertile female immigrants from countries with no vaccination or where vaccination coverage is low should be actively approached for vaccination to reduce the risk of infection and congenital rubella.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442703     DOI: 10.1093/eurpub/ckm034

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  6 in total

1.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

2.  Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Authors:  Irene Barrabeig; Nuria Torner; Ana Martínez; Gloria Carmona; Pilar Ciruela; Joan Batalla; Josep Costa; Sergi Hernández; Luis Salleras; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-08       Impact factor: 3.452

3.  Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia.

Authors:  Ching-Chiang Lin; Chun-Yuh Yang; Ching-Tang Shih; Bai-Hsiun Chen; Yeou-Lih Huang
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

4.  TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.

Authors:  Lin-Chuan Wang; Fang Yan; Jing-Xiong Ruan; Yao Xiao; Yan Yu
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-09       Impact factor: 3.007

5.  Parental knowledge of paediatric vaccination.

Authors:  Eva Borràs; Angela Domínguez; Miriam Fuentes; Joan Batalla; Neus Cardeñosa; Antoni Plasencia
Journal:  BMC Public Health       Date:  2009-05-27       Impact factor: 3.295

Review 6.  Rubella antibody screening during pregnancy in an urban area of Northern Italy.

Authors:  Massimo De Paschale; Maria Teresa Manco; Alessia Paganini; Carlo Agrappi; Paola Mirri; Gabriella Cucchi; Barbara Saccani; Alberto Flores D'Arcais; Pierangelo Clerici
Journal:  Infect Dis Rep       Date:  2012-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.